Targeting β-cell preservation in prediabetes to lower cardiovascular risk: Preclinical assessment of DLK inhibition as an innovative antidiabetic approach
31 August 2026 (10:15 - 11:00)
Organised by: 

Abstract
About the speaker

Institute for Cardiogenetics, Luebeck (Germany)
6 More presentations in this session
Doctor S. Chahin Padilla (Bogota, CO)
Doctor O. Katsarou (Athens, GR)
Access the full session
The Event
ESC Congress 2026
31 August 2026
10:15 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation

